Morgan Stanley Downgrades Rentokil Initial Stock Rating
1 report, 1 independent
Updated Oct 20
AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley downgraded Rentokil Initial's stock rating on October 20, 2026. This action follows a period of varied analyst commentary, including an upgrade from Investec and a previous rating cut from BNP Paribas Exane. The company currently holds an average rating of “Hold” from thirteen analysts covering its stock.
From dailypolitical.com
Why it matters
The rating adjustment reflects shifting market sentiment regarding Rentokil Initial. The company's stock has a current ratio of 1.06 and a quick ratio of 0.98, while the average 12-month target price among brokers is $31.90.
From dailypolitical.com
Who's involved
- Rentokil InitialCompany whose stock rating was adjusted
- Morgan StanleyU.S. investment bank that issued the rating cut
Keep exploring
The entities involved
-
Rentokil Initial
Services business
Nothing else this week.
-
Morgan Stanley
U.S. investment bank